Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-12 | 2023-11-23 | 198391 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-07-11 | 2023-07-21 | 198319 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2023-07-11 | 2023-10-04 | 198312 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Actual shortage | 2023-07-11 | 2024-04-25 | 198309 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Actual shortage | 2023-07-11 | 2024-05-09 | 198306 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-07-11 | 2024-05-03 | 198303 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2024-05-03 | 198292 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2023-07-11 | 2023-12-14 | 198283 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2023-07-11 | 2023-12-14 | 198280 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-07-06 | 2023-07-28 | 197743 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197539 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197507 |
| TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-07-04 | 2023-10-03 | 197282 |
| TEVA-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-07-04 | 2023-08-18 | 197218 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2023-07-04 | 2024-02-07 | 197195 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-07-04 | 2023-10-04 | 197172 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-04 | 2023-08-04 | 197169 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-07-04 | 2023-08-04 | 197104 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-04 | 2023-07-14 | 197052 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-26 | 2023-08-18 | 196476 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |